...
首页> 外文期刊>Advanced drug delivery reviews >Pharmacophore-based discovery of ligands for drug transporters.
【24h】

Pharmacophore-based discovery of ligands for drug transporters.

机译:基于药理学的药物转运体配体发现。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The ability to identify ligands for drug transporters is an important step in drug discovery and development. It can both improve accurate profiling of lead pharmacokinetic properties and assist in the discovery of new chemical entities targeting transporters. In silico approaches, especially pharmacophore-based database screening methods have great potential in improving the throughput of current transporter ligand identification assays, leading to a higher hit rate by focusing in vitro testing to the most promising hits. In this review, the potential of different in silico methods in transporter ligand identification studies are compared and summarized with an emphasis on pharmacophore modeling. Various implementations of pharmacophore model generation, database compilation and flexible screening algorithms are also introduced. Recent successful utilization of database searching with pharmacophores to identify novel ligands for the pharmaceutically significant transporters hPepT1, P-gp, BCRP, MRP1 and DAT are reviewed and the challenges encountered with current approaches are discussed.
机译:识别药物转运蛋白配体的能力是药物发现和开发中的重要一步。它不仅可以改善对前药代动力学特性的准确分析,而且可以帮助发现针对转运蛋白的新化学实体。在计算机方法中,尤其是基于药效团的数据库筛选方法在提高当前转运蛋白配体鉴定测定的通量方面具有巨大潜力,通过将体外测试的重点放在最有希望的命中上,从而可以提高命中率。在这篇综述中,比较和总结了不同计算机方法在转运蛋白配体鉴定研究中的潜力,并着重于药效基团建模。还介绍了药效团模型生成,数据库编译和灵活筛选算法的各种实现。审查了最近成功利用药效基团搜索数据库以鉴定药学上重要的转运蛋白hPepT1,P-gp,BCRP,MRP1和DAT的新配体的方法,并讨论了当前方法所面临的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号